Evaluation and Management of the Complications of Lung Cancer Treatment

Mei-Lin W. Ah-See; Stephen G. Spiro

doi:10.1055/s-2000-9407

Seminars in Respiratory and Critical Care Medicine, Table of Contents

Semin Respir Crit Care Med 2000; Volume 21(Number 05): 451-462
DOI: 10.1055/s-2000-9407

Evaluation and Management of the Complications of Lung Cancer Treatment

Mei-Lin W. Ah-See¹ , Stephen G. Spiro²

¹Clinical Oncology, The Middlesex Hospital, University College London Hospitals, London, United Kingdom
²Department of Respiratory Medicine, The Middlesex Hospital, University College London Hospitals, London, United Kingdom

Abstract

ABSTRACT

The principal treatment-related complications encountered in the management of lung cancer are presented with particular reference to surgery, radiotherapy, and chemotherapy. The clinical features, risk factors, and management of the complications are discussed.

KEYWORD

Lung cancer - surgery - radiotherapy - chemotherapy - complications

Full Text

References

REFERENCES

1 McIntosh H C, Spitz S. A study of radiation pneumonitis. AJR . 1939; 41 605-615
2 Van der Kogel A J, Ang K K. Complications related to radiotherapy. In: Peckham M, Pinedo H, Veronesi U, eds. Oxford Textbook of Oncology Oxford: Oxford University Press, 1995: 2295-306
3 Pearson F G. Current status of surgical resection for lung cancer. Chest . 1994; 106 337-339S
4 Silverberg E, Boring C C, Squires T S. Cancer Statistics. CA Cancer J Clin . 1990; 40 9-26
5 Deslauriers J, Ginsberg R J, Fournier B. Prospective assessment of 30-day operative morbidity for surgical resections in lung cancer. Chest . 1994; 106 329-330S
6 Ginsberg R J, Hill L D, Eagan R T. Modern thirty-day operative mortality for surgical resection in lung cancer. J Thorac Cardiovasc Surg . 1983; 86 654-658
7 Markos J, Mullan B P, Hillman D R. Preoperative assessment as a predictor of mortality and morbidity after lung resection. Am Rev Respir Dis . 1989; 139 902-910
8 Nagasaki F, Flehinger B J, Martini N. Complications of surgery in the treatment of carcinoma of the lung. Chest . 1982; 82 25-29
9 Wyser C, Stulz P, Soler M. Prospective evaluation of an algorithm for the functional assessment of lung resection candidates. Am J Respir Crit Care Med . 1999; 159 1450-1456
10 Van der Kogel A J. Radiation response and tolerance of normal tissues. In: Steel GG, ed. Basic Clinical Radiobiology. London: Arnold; . 1997; 30-39
11 Movsas B, Raffin T A, Epstein A H. Pulmonary radiation injury. Chest . 1997; 111 1061-1076
12 Davies S D, Yankelevitz D F, Henschke C I. Radiation effects on the lung: Clinical features, Pathology, and Imaging Findings. AJR . 1992; 159 1157-1164
13 Van Houtte P. Mornex P. Radiotherapy of non-small-cell and small-cell and SCLC. Lung cancer. In: Spiro SG, ed. Carcinoma of the Lung. European Respiratory Monograph, vol. 1 Oct. 1995: 241-268
14 Fried J R, Goldberg H. Post-irradiation changes in the lung and thorax. Am J Roentgenol . 1940; 43 877-895
15 Ross W M. Radiotherapeutic and radiological aspects of radiation fibrosis of the lungs. Thorax . 1956; 11 241-246
16 Libshitz H I, Southard M E. Complications of radiation therapy: The thorax. Semin Roentgenol . 1974; 9 41-49
17 Roswit B, White D C. Severe radiation injuries of the lung. AJR . 1977; 129 127-136
18 Bate D, Guttemann R J. Changes in the lung and pleura following 2-million volt therapy for carcinoma of the breast. Radiology . 1957; 69 372-382
19 Bachman A L, Macken K. Pleural effusions following supervoltage radiation for breast carcinoma. Radiology . 1959; 72 699-709
20 Libshitz H I, Southard M E. Complications of radiation therapy: The thorax. Semin Roentgenol . 1974; 9 41-49
21 Pagani J J, Libshitz H I. CT manifestations of radiation-induced change in chest tissue. J Comput Assist Tomogr . 1982; 6 243-248
22 Libshitz H I, Shuman L S. Radiation-induced pulmonary change: CT findings. J Comput Assist Tomogr . 1984; 8 15-19
23 Mah K, Poon P Y, Van Dyk J. Assessment of acute radiation-induced pulmonary changes using computed tomography. J Comput Assist Tomogr . 1986; 10 736-743
24 Bourgouin P, Cousineau G, Lemire P. Differentiation of radiation-induced fibrosis from recurrent pulmonary neoplasm by CT. Can Assoc Radiol J . 1987; 38 23-26
25 Ikezoe J, Takashima S, Morimoto S. CT appearance of acute radiation-induced injury in the lung. AJR . 1988; 150 765-770
26 Bell J, McGivern D, Bullimore J. Diagnostic imaging of post-irradiation changes in the chest. Clin Radiol . 1988; 39 109-119
27 Frija J, Ferme C, Baud L. Radiation-induced lung injuries: A survey of computed tomography and pulmonary function tests in 18 cases of Hodgkin's disease. Eur J Radiol . 1988; 8 18-23
28 Ikezoe J, Morimoto S, Takashima S. Acute radiation-induced pulmonary injury: Computed tomography evaluation. Semin Ultrasound CT MR . 1990; 11 409-416
29 Glazer H S, Lee J KT, Levitt R G. Radiation fibrosis: Differentiation from recurrent tumor by MR imaging. Radiology . 1985; 156 721-726
30 Kataoka M, Kawamura M, Itho H. Ga-67 citrate scintigraphy for the early detection of radiation pneumonitis. Clin Nucl Med . 1992; 17 27-31
31 Evans R F, Sagerman R H, Ringrose T L. Pulmonary function following mantle-field irradiation for Hodgkin's disease. Radiology . 1974; 111 729-731
32 Brady L W, German P A, Cander L. The effects of radiation therapy on pulmonary function in carcinoma of the lung. Radiology . 1965; 85 130-134
33 Watchie J, Coleman C N, Raffin T A. Minimal long-term cardiopulmonary dysfunction following treatment for Hodgkin's disease. Int J Radiat Oncol Biol Phys . 1987; 13 517-524
34 Lokich J J, Brass H, Eberly F E. The pulmonary effect of mantle irradiation in patients with Hodgkin's disease. Radiology . 1973; 108 397-402
35 Host H, Vale J R. Lung function after mantle field irradiation in Hodgkin's disease. Cancer . 1973; 32 328-332
36 Wolin E M, Rosenberg S A, Kaplan H S. A randomized comparison of PAVe and MOP (P) as adjuvant therapy for Hodgkin's disease. In: Salmon SE, Jones SE, eds. Adjuvant Therapy of Cancer New York: Grune & Stratton, 1979: 119-127
37 Rubin O, Casarett G W. Clinical Radiation Pathology. Philadelphia: WB Saunders, 1968: 423-470
38 Gross N J, Narine K R, Wade R. Protective effect of corticosteroids on radiation pneumonitis in mice. Radiat Res . 1988; 113 112-119
39 Gross N J. Pulmonary effects of radiation therapy. Ann Intern Med . 1977; 86 81-92
40 Castellino R A, Glastein E, Turbow M M. Latent radiation injury of lungs or heart activated by steroid withdrawal. Ann Intern Med . 1974; 80 593-599
41 Rotstein S, Blomgren H, Baral E. Incidence of infectious symptoms after radiation therapy for breast cancer: Long-term effects. Acta Oncol . 1987; 26 197-201
42 Gross N j, Holloway N O, Narine K R. Effects of nonsteroidal anti-inflammatory agents on experimental radiation pneumonitis. Radiat Res . 1991; 127 317-324
43 Coggle J E, Lambert B E, Moores S R. Radiation effects in the lung. Environ Health Perspect . 1986; 70 261-291
44 Gross N J. Pulmonary effects of radiation therapy. Ann Intern Med . 1977; 86 81-92
45 Roswitt B, White D C. Severe radiation injuries of the lung. AJR . 1977; 129 127-136
46 Bennett D E, Million R R, Ackerman L V. Bilateral radiation pneumonitis, a complication of the radiotherapy of bronchogenic carcinoma. Cancer . 1969; 23 1001-1018
47 Stone D J, Schwartz M J, Green R A. Fatal pulmonary insufficiency due to radiation effect upon the lung. Am J Med . 1956; 21 211-226
48 Whitfield G W, Bond W H, Arnott W M. Radiation reactions in the lung. Q J Med . 1956; 97 69-86
49 Kaufman J, Komorowski R. Bronchiolitis obliterans, a new clinical-pathologic complication of irradiation pneumonitis. Chest . 1990; 97 1243-1244
50 Crestani B, Kambouchner M, Soler P. Migratory bronchiolitis obliterans organizing pneumonia after unilateral radiation therapy for breast carcinoma. Eur Respir J . 1995; 8 318-321
51 Bayle J Y, Nesme P, Bejui-Thivolet F. Migratory organizing pneumonitis ``primed'' by radiation therapy. Eur Respir J . 1995; 8 322-326
52 Van Laar J M, Holscher H C, Van Krieken J HJM. Bronchiolitis obliterans organizing pneumonia after adjuvant radiotherapy for breast carcinoma. Respir Med . 1997; 91 241-244
53 Crestani B, Valeyre D, Roden S. Bronchiolitis obliterans organising pneumonia syndrome primed by radiation therapy to the breast. Am J Respir Crit Care Med . 1998; 158 1929-1935
54 Martin C, Romero S, Sanchez-Paya J. Bilateral lymphocytic alveolitis: A common reaction after unilateral thoracic irradiation. Eur Respir J . 1999; 13 727-732
55 Prakash U BS. Radiation-induced injury in the ``nonirradiated'' lung. Eur Respir J . 1999; 13 715-717
56 Stewart J R, Fajardo L F. Radiation-induced heart disease: An update. Prog Cardiovasc Dis . 1984; 27 173-194
57 Schultz-Hector S. Heart. In: Scherer E, Streffer C, Trott KR, eds. Radiopathology of Organs and Tissues Berlin: Springer-Verlag, 1991: 347-368
58 Brosius F C, Waller B F, Roberts W L. Analysis of 16 young (aged 15-33 years) necropsy patients who received over 3500 rads to the heart. Am J Med . 1981; 70 519-530
59 PORT Meta-analysis Trialists Group. Postoperative radiotherapy in non-small-cell lung cancer: Systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet . 1998; 352 257-263
60 Dautzenberg B, Arriagada R, Chammard A B. A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Cancer . 1999; 86 265-273
61 Van der Kogel AJ. The nervous system: Radiobiology and experimental pathology. In: SchererE, Streffer C, Trott, eds. Radiopathology of Organs and Tissues Heidelberg: Springer-Verlag, 1991: 191-212
62 Macbeth F R, Wheldon, T E, Girling D J. Radiation myelopathy: Estimates of risk in 1048 patients in three randomised trials of palliative radiotherapy for non-small cell lung cancer. Clin Oncol . 1996; 8 176-181
63 Glantz M J, Choy H, Yee L. Prophylactic cranial irradiation in small cell lung cancer: Rationale, results, and recommendations. Semin Oncol . 1997; 24 477-483
64 Auperin A, Arriagada R, Pignon J P. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Engl J Med . 1999; 341 476-484
65 Feld R, Clamon G H, Blunn R. Short course prophylactic cranial irradiation for small cell lung cancer. Am J Clin Oncol . 1985; 8 371-376
66 Posner J B. Neurologic Complications of Cancer. Philadelphia, PA: FA Davies, 1995: 96-100
67 Perez C A, Einhorn L, Oldham R K. Randomized trial of radiotherapy to the thorax in limited small cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation: A preliminary report. J Clin Oncol . 1984; 2 1200-1208
68 Catane R, Schwade J G, Yarr I. Follow-up and neurological evaluation in patients with small cell lung carcinoma treated with prophylactic cranial irradiation and chemotherapy. Int J Radiat Oncol Biol Phys . 1981; 7 105-109
69 Johnson B E, Patronas N, Hayes W. Neurologic, computed cranial tomographic, and magnetic resonance imaging abnormalities in patients with small-cell lung carcinoma: Further follow-up of 6- to 13-year survivors. J Clin Oncol . 1990; 8 48-56
70 Lee J S, Umsawasdi T, Lee Y Y. Neurotoxicity in long-term survivors of small cell lung cancer. Int J Radiat Oncol Biol Phys . 1986; 12 313-321
71 Lishner M, Feld R, Payne D G. Late neurological complications after prophylactic cranial irradiation in patients with small-cell lung cancer: The Toronto experience. J Clin Oncol . 1990; 8 215-221
72 Frytak S, Shaw J N, O'Neill B P. Leukoencephalopathy in small cell lung cancer patients receiving prophylactic cranial irradiation. Am J Clin Oncol . 1989; 12 27-33
73 Ahles T A, Silberfarb P M, Herndon II J. Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: A study by the Cancer and Leukaemia Group B. J Clin Oncol . 1998; 16 1954-1960
74 Arriagada R, Le Chevalier T, Borie F. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst . 1995; 87 183-190
75 Gregor A, Cull A, Stephens R J. Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: Results of a multicentre randomised trial. Eur J Cancer . 1997; 33 1752-1758
76 Johnson B E, Cortazar P, Chute J P. Second lung cancers in patients successfully treated for lung cancer. Semin Oncol . 1997; 24 1-9
77 Van Bodegom P Cv, Wagenaar S S, Corrin B. Second primary lung cancer: Importance of long term follow up. Thorax . 1989; 44 788-793
78 Sugimura H, Watanabe S, Tsugane S. Case-control study on histologically determined multiple primary lung cancer. J Natl Cancer Inst . 1987; 79 435-441
79 Mathisen D J, Jensik R J, Faber L P. Survival following resection for second and third primary lung cancers. J Thorac Cardiovasc Surg . 1984; 82 502-510
80 Wu S C, Lin Z Q, Xu C W. Multiple primary lung cancers. Chest . 1987; 92 892-896
81 Deschamps C, Pairolero P C, Trastek V F. Multiple primary lung cancers: Results of surgical treatment. Ann Thorac Cardiovasc Surg . 1990; 99 769-778
82 Abrahamsen J F, Andersen A, Hannisdal E. Second malignancies after treatment of Hodgkin's Disease: The influence of treatment, follow-up time, and age. J Clin Oncol . 1993; 11 255-261
83 Swerdlow A J, Douglas A J, Vaughan Hudson G. Risk of second primary cancers after Hodgkin's Disease by type of treatment: Analysis of 2846 patients in the British National Lymphoma Investigation. Br Med J . 1992; 304 1137-1143
84 Tucker M A, Coleman C N, Cox R S. Risk of second cancers after treatment for Hodgkin's Disease. N Engl J Med . 1988; 318 76-81
85 Van Leeuwen F E, Klikman W J, Hagenbeek A. Second cancer risk following Hodgkin's Disease: A 20-year follow-up study. J Clin Oncol . 1994; 12 312-325
86 Kirova Y M, FeuilhadeF, Calitchi E. Radiation-induced sarcoma after breast cancer. Apropos of 8 cases and review of the literature. Cancer-Radiother . 1998; 2 381-386
87 Ihde D c. Drug therapy. Chemotherapy for lung cancer. N Engl J Med . 1992; 12 1434-1441
88 Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. Br Med J . 1995; 11 899-909
89 Smit E F, Postmus P E. Chemotherapy of small cell lung cancer. In: Carney DN, ed. Lung cancer London: Edward Arnold, 1995: 156-172
90 Rosell R, Gomez-Codina J, Camps C. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med . 1994; 330 153-158
91 Roth J A, Fossell F, Komaki R. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst . 1994; 86 673-680
92 Weiss R B, Vogelzang N J. Miscellaneous toxicities. In: Devita, VT Jnr, Hellman S, Rosenberg SA, eds. Cancer. Principles and Practice of Oncology Philadelphia: JB Lippincott Company, 1993: 2349-2358
93 Steinherz L J, Yahalom J. Cardiac complications of cancer therapy. In: Devita, VT Jnr, Hellman S, Rosenberg SA, eds. Cancer. Principles and Practice of Oncology Philadelphia: JB Lippincott Company, 1993: 2370-2385
94 Talcott J A, Finberg R, Mayer R J. The medical course of cancer patients with fever and neutropenia: Clinical identification of a low-risk subgroup at presentation. Arch Intern Med . 1988; 148 2561-2568
95 Talcott J A, Siegel R D, Finberg R. Risk assessment in cancer patients with fever and neutropenia: A prospective, two-center validation of a prediction rule. J Clin Oncol . 1992; 10 316-322
96 Freifeld A, Marchigiani D, Walsh T. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. N Engl J Med . 1999; 341 305-311
97 Kern W V, Cometta A, De Bock R. Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. N Engl J Med . 1999; 341 312-318
98 Hirsch F R, Hansen H H, Hansen M. The superiority of combination chemotherapy including etoposide based on in vivo cycle analysis in the treatment of small-cell lung cancer: A randomised trial of 288 consecutive patients. J Clin Oncol . 1987; 5 585-591
99 Stephens R J, Girling D J, Machin D. Treatment related deaths in small cell lung cancer trials: Can patients at risk be identified?. Lung Cancer . 1994; 11 259-274
100 Morittu L, Earl H M, Souhami R L. Patients at risk of chemotherapy-associated toxicity in small cell lung cancer. Br J Cancer . 1989; 59 801-804
101 Johnson D H. Small cell lung cancer in the elderly patient. Semin Oncol . 1997; 24 484-491
102 Urban T, Lebeau B. Colony-stimulating factor therapy and febrile neutropenia induced by chemotherapy: Need for economical studies. Eur Respir J . 1999; 13 1228-1229
103 Crawford J, Ozer H, Stoller R. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med . 1991; 325 164-170
104 Trillet-Lehoir V, Green J, Manegold C. Recombinant granulocyte colony-stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer . 1993; 29 319-324
105 Maher D W, Lieschke G J, Green M. Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial. Ann Intern Med . 1994; 121 492-501
106 Mayordomo J I, Rivera F, Diaz-Puente M. Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors. J Natl Cancer Inst . 1995; 87 803-808
107 Anaissie E J, Vartivarian S, Bodey G P. Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived) in cancer patients with fever and neutropenia. Am J Med . 1996; 100 17-23
108 Cooper J AD, White D A, Matthay R A. Drug-induced pulmonary disease. Part 1: Cytotoxic drugs. Am Rev Respir Dis . 1986; 133 321-340
109 Israel-Biet D, Labrune S, Huchon, G J. Drug-induced lung disease: 1990 review. Eur Respir J . 1991; 4 465-478
110 Foucher P, Biour M, Blayac J P. Drugs which may injure the respiratory system. Eur Respir J . 1997; 10 265-279
111 Hesketh P J, Gandara. A new class of antiemetic agents. J Natl Cancer Inst . 1991; 83 613-620